Atsushi Tanaka, Hiroyoshi Nishikawa, Shinsuke Noguchi, Daisuke Sugiyama, Hiromasa Morikawa, Yoshiko Takeuchi, Danbee Ha, Naoya Shigeta, Toshio Kitawaki, Yuka Maeda, Takuro Saito, Yoshinori Shinohara, Yoshihiro Kameoka, Keiko Iwaisako, Fumihiko Monma, Kohshi Ohishi, Julia Karbach, Elke Jäger, Kenichi Sawada, Naoyuki Katayama, Naoto Takahashi, Shimon Sakaguchi |
Atsushi Tanaka, Hiroyoshi Nishikawa, Shinsuke Noguchi, Daisuke Sugiyama, Hiromasa Morikawa, Yoshiko Takeuchi, Danbee Ha, Naoya Shigeta, Toshio Kitawaki, Yuka Maeda, Takuro Saito, Yoshinori Shinohara, Yoshihiro Kameoka, Keiko Iwaisako, Fumihiko Monma, Kohshi Ohishi, Julia Karbach, Elke Jäger, Kenichi Sawada, Naoyuki Katayama, Naoto Takahashi, Shimon Sakaguchi |
Atsushi Tanaka, Hiroyoshi Nishikawa, Shinsuke Noguchi, Daisuke Sugiyama, Hiromasa Morikawa, Yoshiko Takeuchi, Danbee Ha, Naoya Shigeta, Toshio Kitawaki, Yuka Maeda, Takuro Saito, Yoshinori Shinohara, Yoshihiro Kameoka, Keiko Iwaisako, Fumihiko Monma, Kohshi Ohishi, Julia Karbach, Elke Jäger, Kenichi Sawada, Naoyuki Katayama, Naoto Takahashi, Shimon Sakaguchi |
Tyrosine kinase inhibitor imatinib augments tumor immunity by depleting effector regulatory T cells. |
Tyrosine kinase inhibitor imatinib augments tumor immunity by depleting effector regulatory T cells. |
Tyrosine kinase inhibitor imatinib augments tumor immunity by depleting effector regulatory T cells. |
The Journal of experimental medicine, 217, 2 |
The Journal of experimental medicine, 217, 2 |
The Journal of experimental medicine, 217, 2 |
2020/02/03 |
Refereed |
English |
|
Disclose to all |
Yamamoto K, Kitawaki T, Sugimoto N, Fujita H, Kawase Y, Takaori-Kondo A, Kadowaki N |
Yamamoto K, Kitawaki T, Sugimoto N, Fujita H, Kawase Y, Takaori-Kondo A, Kadowaki N |
Yamamoto K, Kitawaki T, Sugimoto N, Fujita H, Kawase Y, Takaori-Kondo A, Kadowaki N |
Anti-inflammatory modulation of human myeloid-derived dendritic cell subsets by lenalidomide. |
Anti-inflammatory modulation of human myeloid-derived dendritic cell subsets by lenalidomide. |
Anti-inflammatory modulation of human myeloid-derived dendritic cell subsets by lenalidomide. |
Immunology letters, 211, 41-48 |
Immunology letters, 211, 41-48 |
Immunology letters, 211, 41-48 |
2019/07 |
Refereed |
|
|
Disclose to all |
Ichiro Yamauchi, Akihiro Yasoda, Shigemi Matsumoto, Yuichi Sakamori, Young Hak Kim, Motoo Nomura, Atsushi Otsuka, Toshinari Yamasaki, Ryoichi Saito, Morimasa Kitamura, Toshio Kitawaki, Masakatsu Hishizawa, Nobuko Kawaguchi-Sakita, Toshihito Fujii, Daisuke Taura, Masakatsu Sone, Nobuya Inagaki |
Ichiro Yamauchi, Akihiro Yasoda, Shigemi Matsumoto, Yuichi Sakamori, Young Hak Kim, Motoo Nomura, Atsushi Otsuka, Toshinari Yamasaki, Ryoichi Saito, Morimasa Kitamura, Toshio Kitawaki, Masakatsu Hishizawa, Nobuko Kawaguchi-Sakita, Toshihito Fujii, Daisuke Taura, Masakatsu Sone, Nobuya Inagaki |
Ichiro Yamauchi, Akihiro Yasoda, Shigemi Matsumoto, Yuichi Sakamori, Young Hak Kim, Motoo Nomura, Atsushi Otsuka, Toshinari Yamasaki, Ryoichi Saito, Morimasa Kitamura, Toshio Kitawaki, Masakatsu Hishizawa, Nobuko Kawaguchi-Sakita, Toshihito Fujii, Daisuke Taura, Masakatsu Sone, Nobuya Inagaki |
Incidence, features, and prognosis of immune-related adverse events involving the thyroid gland induced by nivolumab.  |
Incidence, features, and prognosis of immune-related adverse events involving the thyroid gland induced by nivolumab.  |
Incidence, features, and prognosis of immune-related adverse events involving the thyroid gland induced by nivolumab.  |
PloS one, 14, 5, e0216954 |
PloS one, 14, 5, e0216954 |
PloS one, 14, 5, e0216954 |
2019 |
Refereed |
English |
|
Disclose to all |
Kadowaki N, Ishiyama K, Kitawaki T |
Kadowaki N, Ishiyama K, Kitawaki T |
Kadowaki N, Ishiyama K, Kitawaki T |
Cytomegalovirus pulls strings behind NK cells. |
Cytomegalovirus pulls strings behind NK cells. |
Cytomegalovirus pulls strings behind NK cells. |
Oncotarget, 8, 55, 93297-93298 |
Oncotarget, 8, 55, 93297-93298 |
Oncotarget, 8, 55, 93297-93298 |
2017/11 |
Refereed |
|
|
Disclose to all |
K-I Ishiyama, T. Kitawaki, N. Sugimoto, T. Sozu, N. Anzai, M. Okada, M. Nohgawa, K. Hatanaka, N. Arima, T. Ishikawa, S. Tabata, T. Onaka, S. Oka, Y. Nakabo, R. Amakawa, M. Matsui, T. Moriguchi, A. Takaori-Kondo, N. Kadowaki |
K-I Ishiyama, T. Kitawaki, N. Sugimoto, T. Sozu, N. Anzai, M. Okada, M. Nohgawa, K. Hatanaka, N. Arima, T. Ishikawa, S. Tabata, T. Onaka, S. Oka, Y. Nakabo, R. Amakawa, M. Matsui, T. Moriguchi, A. Takaori-Kondo, N. Kadowaki |
K-I Ishiyama, T. Kitawaki, N. Sugimoto, T. Sozu, N. Anzai, M. Okada, M. Nohgawa, K. Hatanaka, N. Arima, T. Ishikawa, S. Tabata, T. Onaka, S. Oka, Y. Nakabo, R. Amakawa, M. Matsui, T. Moriguchi, A. Takaori-Kondo, N. Kadowaki |
Principal component analysis uncovers cytomegalovirus-associated NK cell activation in Ph+ leukemia patients treated with dasatinib |
Principal component analysis uncovers cytomegalovirus-associated NK cell activation in Ph+ leukemia patients treated with dasatinib |
Principal component analysis uncovers cytomegalovirus-associated NK cell activation in Ph+ leukemia patients treated with dasatinib |
LEUKEMIA, 31, 1, 203-212 |
LEUKEMIA, 31, 1, 203-212 |
LEUKEMIA, 31, 1, 203-212 |
2017/01 |
Refereed |
English |
Research paper(scientific journal) |
Disclose to all |
Maeda T, Nagano S, Ichise H, Kataoka K, Yamada D, Ogawa S, Koseki H, Kitawaki T, Kadowaki N, Takaori-Kondo A, Masuda K, Kawamoto H |
Maeda T, Nagano S, Ichise H, Kataoka K, Yamada D, Ogawa S, Koseki H, Kitawaki T, Kadowaki N, Takaori-Kondo A, Masuda K, Kawamoto H |
|
Regeneration of CD8αβ T Cells from T-cell-Derived iPSC Imparts Potent Tumor Antigen-Specific Cytotoxicity. |
Regeneration of CD8αβ T Cells from T-cell-Derived iPSC Imparts Potent Tumor Antigen-Specific Cytotoxicity. |
|
Cancer Res., 76, 23, 6839-6850 |
Cancer Res., 76, 23, 6839-6850 |
, 76, 23, 6839-6850 |
2016/12 |
Refereed |
|
|
Disclose to all |
Kishimoto W, Nishikori M, Arima H, Miyoshi H, Sasaki Y, Kitawaki T, Shirakawa K, Kato T, Imaizumi Y, Ishikawa T, Ohno H, Haga H, Ohshima K, Takaori-Kondo A |
Kishimoto W, Nishikori M, Arima H, Miyoshi H, Sasaki Y, Kitawaki T, Shirakawa K, Kato T, Imaizumi Y, Ishikawa T, Ohno H, Haga H, Ohshima K, Takaori-Kondo A |
Kishimoto W, Nishikori M, Arima H, Miyoshi H, Sasaki Y, Kitawaki T, Shirakawa K, Kato T, Imaizumi Y, Ishikawa T, Ohno H, Haga H, Ohshima K, Takaori-Kondo A |
Expression of Tim-1 in primary CNS lymphoma.  |
Expression of Tim-1 in primary CNS lymphoma.  |
Expression of Tim-1 in primary CNS lymphoma.  |
Cancer medicine, 5, 11, 3235-3245 |
Cancer medicine, 5, 11, 3235-3245 |
Cancer medicine, 5, 11, 3235-3245 |
2016/11 |
Refereed |
|
|
Disclose to all |
Nishikori M, Kitano T, Kobayashi M, Hishizawa M, Kitawaki T, Kondo T, Yamashita K, Kawabata H, Kadowaki N, Takei Y, Haga H |
Nishikori M, Kitano T, Kobayashi M, Hishizawa M, Kitawaki T, Kondo T, Yamashita K, Kawabata H, Kadowaki N, Takei Y, Haga H |
|
Increased number of peripheral CD8+ T cells but not eosinophils is associated with late-onset skin reactions caused by bendamustine.  |
Increased number of peripheral CD8+ T cells but not eosinophils is associated with late-onset skin reactions caused by bendamustine.  |
|
Int J Hematol., 102, 1, 53-58 |
Int J Hematol., 102, 1, 53-58 |
, 102, 1, 53-58 |
2015/07 |
Refereed |
|
|
Disclose to all |
Toshio Kitawaki |
Toshio Kitawaki |
Toshio Kitawaki |
DC-based immunotherapy for hematological malignancies |
DC-based immunotherapy for hematological malignancies |
DC-based immunotherapy for hematological malignancies |
INTERNATIONAL JOURNAL OF HEMATOLOGY, 99, 2, 117-122 |
INTERNATIONAL JOURNAL OF HEMATOLOGY, 99, 2, 117-122 |
INTERNATIONAL JOURNAL OF HEMATOLOGY, 99, 2, 117-122 |
2014/02 |
Refereed |
English |
Research paper(scientific journal) |
Disclose to all |
Takayuki Sato, Toshio Kitawaki, Haruyuki Fujita, Makoto Iwata, Tomonori Iyoda, Kayo Inaba, Toshiaki Ohteki, Suguru Hasegawa, Kenji Kawada, Yoshiharu Sakai, Hiroki Ikeuchi, Hiroshi Nakase, Akira Niwa, Akifumi Takaori-Kondo, Norimitsu Kadowaki |
Takayuki Sato, Toshio Kitawaki, Haruyuki Fujita, Makoto Iwata, Tomonori Iyoda, Kayo Inaba, Toshiaki Ohteki, Suguru Hasegawa, Kenji Kawada, Yoshiharu Sakai, Hiroki Ikeuchi, Hiroshi Nakase, Akira Niwa, Akifumi Takaori-Kondo, Norimitsu Kadowaki |
Takayuki Sato, Toshio Kitawaki, Haruyuki Fujita, Makoto Iwata, Tomonori Iyoda, Kayo Inaba, Toshiaki Ohteki, Suguru Hasegawa, Kenji Kawada, Yoshiharu Sakai, Hiroki Ikeuchi, Hiroshi Nakase, Akira Niwa, Akifumi Takaori-Kondo, Norimitsu Kadowaki |
Human CD1c⁺ myeloid dendritic cells acquire a high level of retinoic acid-producing capacity in response to vitamin D₃. |
Human CD1c⁺ myeloid dendritic cells acquire a high level of retinoic acid-producing capacity in response to vitamin D₃. |
Human CD1c⁺ myeloid dendritic cells acquire a high level of retinoic acid-producing capacity in response to vitamin D₃. |
Journal of immunology (Baltimore, Md. : 1950), 191, 6, 3152-60 |
Journal of immunology (Baltimore, Md. : 1950), 191, 6, 3152-60 |
Journal of immunology (Baltimore, Md. : 1950), 191, 6, 3152-60 |
2013/09/15 |
Refereed |
English |
|
Disclose to all |
Haruyuki Fujita, Toshio Kitawaki, Takayuki Sato, Takahiro Maeda, Shimeru Kamihira, Akifumi Takaori-Kondo, Norimitsu Kadowaki |
Haruyuki Fujita, Toshio Kitawaki, Takayuki Sato, Takahiro Maeda, Shimeru Kamihira, Akifumi Takaori-Kondo, Norimitsu Kadowaki |
Haruyuki Fujita, Toshio Kitawaki, Takayuki Sato, Takahiro Maeda, Shimeru Kamihira, Akifumi Takaori-Kondo, Norimitsu Kadowaki |
The tyrosine kinase inhibitor dasatinib suppresses cytokine production by plasmacytoid dendritic cells by targeting endosomal transport of CpG DNA |
The tyrosine kinase inhibitor dasatinib suppresses cytokine production by plasmacytoid dendritic cells by targeting endosomal transport of CpG DNA |
The tyrosine kinase inhibitor dasatinib suppresses cytokine production by plasmacytoid dendritic cells by targeting endosomal transport of CpG DNA |
EUROPEAN JOURNAL OF IMMUNOLOGY, 43, 1, 93-103 |
EUROPEAN JOURNAL OF IMMUNOLOGY, 43, 1, 93-103 |
EUROPEAN JOURNAL OF IMMUNOLOGY, 43, 1, 93-103 |
2013/01 |
Refereed |
English |
Research paper(scientific journal) |
Disclose to all |
N. Kadowaki, T. Kitawaki |
N. Kadowaki, T. Kitawaki |
N. Kadowaki, T. Kitawaki |
Cellular immunotherapy for leukemia |
Cellular immunotherapy for leukemia |
Cellular immunotherapy for leukemia |
Drug Delivery System, 28, 1, 10-16 |
Drug Delivery System, 28, 1, 10-16 |
Drug Delivery System, 28, 1, 10-16 |
2013 |
Refereed |
English |
|
Disclose to all |
Kawabata H, Kadowaki N, Nishikori M, Kitawaki T, Kondo T, Ishikawa T, Yoshifuji H, Yamakawa N, Imura Y, Mimori T, Matsumura Y, Miyachi Y, Matsubara T, Yanagita M, Haga H, Takaori-Kondo A |
Kawabata H, Kadowaki N, Nishikori M, Kitawaki T, Kondo T, Ishikawa T, Yoshifuji H, Yamakawa N, Imura Y, Mimori T, Matsumura Y, Miyachi Y, Matsubara T, Yanagita M, Haga H, Takaori-Kondo A |
Kawabata H, Kadowaki N, Nishikori M, Kitawaki T, Kondo T, Ishikawa T, Yoshifuji H, Yamakawa N, Imura Y, Mimori T, Matsumura Y, Miyachi Y, Matsubara T, Yanagita M, Haga H, Takaori-Kondo A |
Clinical features and treatment of multicentric castleman's disease : a retrospective study of 21 Japanese patients at a single institute. |
Clinical features and treatment of multicentric castleman's disease : a retrospective study of 21 Japanese patients at a single institute. |
Clinical features and treatment of multicentric castleman's disease : a retrospective study of 21 Japanese patients at a single institute. |
Journal of clinical and experimental hematopathology : JCEH, 53, 1, 69-77 |
Journal of clinical and experimental hematopathology : JCEH, 53, 1, 69-77 |
Journal of clinical and experimental hematopathology : JCEH, 53, 1, 69-77 |
2013 |
Refereed |
|
|
Disclose to all |
Toshio Kitawaki, Norimitsu Kadowaki, Keiko Fukunaga, Yasunari Kasai, Taira Maekawa, Katsuyuki Ohmori, Takashige Kondo, Ryuji Maekawa, Masashi Takahara, Mie Nieda, Kiyotaka Kuzushima, Takayuki Ishikawa, Takashi Uchiyama |
Toshio Kitawaki, Norimitsu Kadowaki, Keiko Fukunaga, Yasunari Kasai, Taira Maekawa, Katsuyuki Ohmori, Takashige Kondo, Ryuji Maekawa, Masashi Takahara, Mie Nieda, Kiyotaka Kuzushima, Takayuki Ishikawa, Takashi Uchiyama |
Toshio Kitawaki, Norimitsu Kadowaki, Keiko Fukunaga, Yasunari Kasai, Taira Maekawa, Katsuyuki Ohmori, Takashige Kondo, Ryuji Maekawa, Masashi Takahara, Mie Nieda, Kiyotaka Kuzushima, Takayuki Ishikawa, Takashi Uchiyama |
A phase I/IIa clinical trial of immunotherapy for elderly patients with acute myeloid leukaemia using dendritic cells co-pulsed with WT1 peptide and zoledronate |
A phase I/IIa clinical trial of immunotherapy for elderly patients with acute myeloid leukaemia using dendritic cells co-pulsed with WT1 peptide and zoledronate |
A phase I/IIa clinical trial of immunotherapy for elderly patients with acute myeloid leukaemia using dendritic cells co-pulsed with WT1 peptide and zoledronate |
BRITISH JOURNAL OF HAEMATOLOGY, 153, 6, 796-799 |
BRITISH JOURNAL OF HAEMATOLOGY, 153, 6, 796-799 |
BRITISH JOURNAL OF HAEMATOLOGY, 153, 6, 796-799 |
2011/06 |
Refereed |
English |
|
Disclose to all |
Toshio Kitawaki, Norimitsu Kadowaki, Keiko Fukunaga, Yasunari Kasai, Taira Maekawa, Katsuyuki Ohmori, Tatsuya Itoh, Akira Shimizu, Kiyotaka Kuzushima, Tadakazu Kondo, Takayuki Ishikawa, Takashi Uchiyama |
Toshio Kitawaki, Norimitsu Kadowaki, Keiko Fukunaga, Yasunari Kasai, Taira Maekawa, Katsuyuki Ohmori, Tatsuya Itoh, Akira Shimizu, Kiyotaka Kuzushima, Tadakazu Kondo, Takayuki Ishikawa, Takashi Uchiyama |
Toshio Kitawaki, Norimitsu Kadowaki, Keiko Fukunaga, Yasunari Kasai, Taira Maekawa, Katsuyuki Ohmori, Tatsuya Itoh, Akira Shimizu, Kiyotaka Kuzushima, Tadakazu Kondo, Takayuki Ishikawa, Takashi Uchiyama |
Cross-priming of CD8(+) T cells in vivo by dendritic cells pulsed with autologous apoptotic leukemic cells in immunotherapy for elderly patients with acute myeloid leukemia  |
Cross-priming of CD8(+) T cells in vivo by dendritic cells pulsed with autologous apoptotic leukemic cells in immunotherapy for elderly patients with acute myeloid leukemia  |
Cross-priming of CD8(+) T cells in vivo by dendritic cells pulsed with autologous apoptotic leukemic cells in immunotherapy for elderly patients with acute myeloid leukemia  |
EXPERIMENTAL HEMATOLOGY, 39, 4, 424-433 |
EXPERIMENTAL HEMATOLOGY, 39, 4, 424-433 |
EXPERIMENTAL HEMATOLOGY, 39, 4, 424-433 |
2011/04 |
Refereed |
English |
Research paper(scientific journal) |
Disclose to all |
Makiko Hirai, Norimitsu Kadowaki, Toshio Kitawaki, Haruyuki Fujita, Akifumi Takaori-Kondo, Ryutaro Fukui, Kensuke Miyake, Takahiro Maeda, Shimeru Kamihira, Yoshiki Miyachi, Takashi Uchiyama |
Makiko Hirai, Norimitsu Kadowaki, Toshio Kitawaki, Haruyuki Fujita, Akifumi Takaori-Kondo, Ryutaro Fukui, Kensuke Miyake, Takahiro Maeda, Shimeru Kamihira, Yoshiki Miyachi, Takashi Uchiyama |
Makiko Hirai, Norimitsu Kadowaki, Toshio Kitawaki, Haruyuki Fujita, Akifumi Takaori-Kondo, Ryutaro Fukui, Kensuke Miyake, Takahiro Maeda, Shimeru Kamihira, Yoshiki Miyachi, Takashi Uchiyama |
Bortezomib suppresses function and survival of plasmacytoid dendritic cells by targeting intracellular trafficking of Toll-like receptors and endoplasmic reticulum homeostasis |
Bortezomib suppresses function and survival of plasmacytoid dendritic cells by targeting intracellular trafficking of Toll-like receptors and endoplasmic reticulum homeostasis |
Bortezomib suppresses function and survival of plasmacytoid dendritic cells by targeting intracellular trafficking of Toll-like receptors and endoplasmic reticulum homeostasis |
BLOOD, 117, 2, 500-509 |
BLOOD, 117, 2, 500-509 |
BLOOD, 117, 2, 500-509 |
2011/01 |
Refereed |
English |
Research paper(scientific journal) |
Disclose to all |
N. Kadowaki, T. Kitawaki, M. Hirai |
N. Kadowaki, T. Kitawaki, M. Hirai |
N. Kadowaki, T. Kitawaki, M. Hirai |
[Therapy for malignancies and inflammatory disorders by modulating human dendritic cell functions]. |
[Therapy for malignancies and inflammatory disorders by modulating human dendritic cell functions]. |
[Therapy for malignancies and inflammatory disorders by modulating human dendritic cell functions]. |
[Rinshō ketsueki] The Japanese journal of clinical hematology, 52, 7, 497-504 |
[Rinshō ketsueki] The Japanese journal of clinical hematology, 52, 7, 497-504 |
[Rinshō ketsueki] The Japanese journal of clinical hematology, 52, 7, 497-504 |
2011 |
Refereed |
English |
|
Disclose to all |
Norimitsu Kadowaki, Toshio Kitawaki |
Norimitsu Kadowaki, Toshio Kitawaki |
Norimitsu Kadowaki, Toshio Kitawaki |
Recent Advance in Antigen-Specific Immunotherapy for Acute Myeloid Leukemia  |
Recent Advance in Antigen-Specific Immunotherapy for Acute Myeloid Leukemia  |
Recent Advance in Antigen-Specific Immunotherapy for Acute Myeloid Leukemia  |
CLINICAL & DEVELOPMENTAL IMMUNOLOGY, 2011 |
CLINICAL & DEVELOPMENTAL IMMUNOLOGY, 2011 |
CLINICAL & DEVELOPMENTAL IMMUNOLOGY, 2011 |
2011 |
Refereed |
English |
|
Disclose to all |
Kitawaki, T, Kadowaki, T, Fukunaga, K, Kasai, Y, Maekawa, T, Ohmori, K, Itoh, T, Tada, H, Teramukai, S, Shimizu, A, Fukushima, M, Kuzushima, K, Kondo, T, Ishikawa, T, Uchiyama, T |
Kitawaki, T, Kadowaki, T, Fukunaga, K, Kasai, Y, Maekawa, T, Ohmori, K, Itoh, T, Tada, H, Teramukai, S, Shimizu, A, Fukushima, M, Kuzushima, K, Kondo, T, Ishikawa, T, Uchiyama, T |
Kitawaki, T, Kadowaki, T, Fukunaga, K, Kasai, Y, Maekawa, T, Ohmori, K, Itoh, T, Tada, H, Teramukai, S, Shimizu, A, Fukushima, M, Kuzushima, K, Kondo, T, Ishikawa, T, Uchiyama, T |
A phase I/II study of immunotherapy for elderly patients with acute myeloid leukemia using dendritic cells pulsed with autologous apoptotic leukemic cells. |
A phase I/II study of immunotherapy for elderly patients with acute myeloid leukemia using dendritic cells pulsed with autologous apoptotic leukemic cells. |
A phase I/II study of immunotherapy for elderly patients with acute myeloid leukemia using dendritic cells pulsed with autologous apoptotic leukemic cells. |
Brit J Haematol, 53(6):796-799 |
Brit J Haematol, 53(6):796-799 |
Brit J Haematol, 53(6):796-799 |
2011 |
Refereed |
English |
|
Disclose to all |
Kazue Arimoto-Miyamoto, Norimitsu Kadowaki, Toshio Kitawaki, Satoshi Iwata, Chikao Morimoto, Takashi Uchiyama |
Kazue Arimoto-Miyamoto, Norimitsu Kadowaki, Toshio Kitawaki, Satoshi Iwata, Chikao Morimoto, Takashi Uchiyama |
Kazue Arimoto-Miyamoto, Norimitsu Kadowaki, Toshio Kitawaki, Satoshi Iwata, Chikao Morimoto, Takashi Uchiyama |
Optimal stimulation for CD70 induction on human monocyte-derived dendritic cells and the importance of CD70 in naive CD4+T-cell differentiation |
Optimal stimulation for CD70 induction on human monocyte-derived dendritic cells and the importance of CD70 in naive CD4+T-cell differentiation |
Optimal stimulation for CD70 induction on human monocyte-derived dendritic cells and the importance of CD70 in naive CD4+T-cell differentiation |
IMMUNOLOGY, 130, 1, 137-149 |
IMMUNOLOGY, 130, 1, 137-149 |
IMMUNOLOGY, 130, 1, 137-149 |
2010/05 |
Refereed |
English |
Research paper(scientific journal) |
Disclose to all |
Tomomi Sakai, Momoko Nishikori, Masaharu Tashima, Ryo Yamamoto, Toshio Kitawaki, Akifumi Takaori-Kondo, Takayo Suzuki, Shinobu Tsuzuki, Takashi Uchiyama |
Tomomi Sakai, Momoko Nishikori, Masaharu Tashima, Ryo Yamamoto, Toshio Kitawaki, Akifumi Takaori-Kondo, Takayo Suzuki, Shinobu Tsuzuki, Takashi Uchiyama |
Tomomi Sakai, Momoko Nishikori, Masaharu Tashima, Ryo Yamamoto, Toshio Kitawaki, Akifumi Takaori-Kondo, Takayo Suzuki, Shinobu Tsuzuki, Takashi Uchiyama |
Distinctive cell properties of B cells carrying the BCL2 translocation and their potential roles in the development of lymphoma of germinal center type |
Distinctive cell properties of B cells carrying the BCL2 translocation and their potential roles in the development of lymphoma of germinal center type |
Distinctive cell properties of B cells carrying the BCL2 translocation and their potential roles in the development of lymphoma of germinal center type |
CANCER SCIENCE, 100, 12, 2361-2367 |
CANCER SCIENCE, 100, 12, 2361-2367 |
CANCER SCIENCE, 100, 12, 2361-2367 |
2009/12 |
Refereed |
English |
Research paper(scientific journal) |
Disclose to all |
Mutsumi Hashimoto-Okada, Toshio Kitawaki, Norimitsu Kadowaki, Satoshi Iwata, Chikao Morimoto, Toshiyuki Hori, Takashi Uchiyama |
Mutsumi Hashimoto-Okada, Toshio Kitawaki, Norimitsu Kadowaki, Satoshi Iwata, Chikao Morimoto, Toshiyuki Hori, Takashi Uchiyama |
Mutsumi Hashimoto-Okada, Toshio Kitawaki, Norimitsu Kadowaki, Satoshi Iwata, Chikao Morimoto, Toshiyuki Hori, Takashi Uchiyama |
The CD70-CD27 interaction during the stimulation with dendritic cells promotes naive CD4(+) T cells to develop into T cells producing a broad array of immunostimulatory cytokines in humans  |
The CD70-CD27 interaction during the stimulation with dendritic cells promotes naive CD4(+) T cells to develop into T cells producing a broad array of immunostimulatory cytokines in humans  |
The CD70-CD27 interaction during the stimulation with dendritic cells promotes naive CD4(+) T cells to develop into T cells producing a broad array of immunostimulatory cytokines in humans  |
INTERNATIONAL IMMUNOLOGY, 21, 8, 891-904 |
INTERNATIONAL IMMUNOLOGY, 21, 8, 891-904 |
INTERNATIONAL IMMUNOLOGY, 21, 8, 891-904 |
2009/08 |
Refereed |
English |
Research paper(scientific journal) |
Disclose to all |
N. Kadowaki, T. Kitawaki |
N. Kadowaki, T. Kitawaki |
N. Kadowaki, T. Kitawaki |
Dendritic cell-based tumor immunotherapy. |
Dendritic cell-based tumor immunotherapy. |
Dendritic cell-based tumor immunotherapy. |
[Rinshō ketsueki] The Japanese journal of clinical hematology, 50, 5, 358-363 |
[Rinshō ketsueki] The Japanese journal of clinical hematology, 50, 5, 358-363 |
[Rinshō ketsueki] The Japanese journal of clinical hematology, 50, 5, 358-363 |
2009 |
Refereed |
English |
|
Disclose to all |
Toshio Kitawaki, Norimitsu Kadowaki, Tadakazu Kondo, Takayuki Ishikawa, Tatsuo Ichinohe, Satoshi Teramukai, Masanori Fukushima, Yasunari Kasai, Taira Maekawa, Takashi Uchiyama |
Toshio Kitawaki, Norimitsu Kadowaki, Tadakazu Kondo, Takayuki Ishikawa, Tatsuo Ichinohe, Satoshi Teramukai, Masanori Fukushima, Yasunari Kasai, Taira Maekawa, Takashi Uchiyama |
Toshio Kitawaki, Norimitsu Kadowaki, Tadakazu Kondo, Takayuki Ishikawa, Tatsuo Ichinohe, Satoshi Teramukai, Masanori Fukushima, Yasunari Kasai, Taira Maekawa, Takashi Uchiyama |
Potential of dendritic cell immunotherapy for relapse after allogeneic hematopoietic stem cell transplantation, shown by WT1 peptide- and keyhole limpet hemocyanin-pulsed, donor-derived dendritic cell vaccine for acute myeloid leukemia |
Potential of dendritic cell immunotherapy for relapse after allogeneic hematopoietic stem cell transplantation, shown by WT1 peptide- and keyhole limpet hemocyanin-pulsed, donor-derived dendritic cell vaccine for acute myeloid leukemia |
Potential of dendritic cell immunotherapy for relapse after allogeneic hematopoietic stem cell transplantation, shown by WT1 peptide- and keyhole limpet hemocyanin-pulsed, donor-derived dendritic cell vaccine for acute myeloid leukemia |
AMERICAN JOURNAL OF HEMATOLOGY, 83, 4, 315-317 |
AMERICAN JOURNAL OF HEMATOLOGY, 83, 4, 315-317 |
AMERICAN JOURNAL OF HEMATOLOGY, 83, 4, 315-317 |
2008/04 |
Refereed |
English |
Research paper(scientific journal) |
Disclose to all |
Ryo Yamamoto, Momoko Nishikori, Toshio Kitawaki, Tomomi Sakai, Masakatsu Hishizawa, Masaharu Tashima, Tadakazu Kondo, Katsuyuki Ohmori, Masayuki Kurata, Takamasa Hayashi, Takashi Uchiyama |
Ryo Yamamoto, Momoko Nishikori, Toshio Kitawaki, Tomomi Sakai, Masakatsu Hishizawa, Masaharu Tashima, Tadakazu Kondo, Katsuyuki Ohmori, Masayuki Kurata, Takamasa Hayashi, Takashi Uchiyama |
Ryo Yamamoto, Momoko Nishikori, Toshio Kitawaki, Tomomi Sakai, Masakatsu Hishizawa, Masaharu Tashima, Tadakazu Kondo, Katsuyuki Ohmori, Masayuki Kurata, Takamasa Hayashi, Takashi Uchiyama |
PD-1-PD-1 ligand interaction contributes to immunosuppressive microenvironment of Hodgkin lymphoma |
PD-1-PD-1 ligand interaction contributes to immunosuppressive microenvironment of Hodgkin lymphoma |
PD-1-PD-1 ligand interaction contributes to immunosuppressive microenvironment of Hodgkin lymphoma |
BLOOD, 111, 6, 3220-3224 |
BLOOD, 111, 6, 3220-3224 |
BLOOD, 111, 6, 3220-3224 |
2008/03 |
Refereed |
English |
Research paper(scientific journal) |
Disclose to all |
Toshio Kitawaki, Norimitsu Kadowaki, Naoshi Sugimoto, Naotomo Kambe, Toshiyuki Hori, Yoshiki Miyachi, Tatsutoshi Nakahata, Takashi Uchiyama |
Toshio Kitawaki, Norimitsu Kadowaki, Naoshi Sugimoto, Naotomo Kambe, Toshiyuki Hori, Yoshiki Miyachi, Tatsutoshi Nakahata, Takashi Uchiyama |
Toshio Kitawaki, Norimitsu Kadowaki, Naoshi Sugimoto, Naotomo Kambe, Toshiyuki Hori, Yoshiki Miyachi, Tatsutoshi Nakahata, Takashi Uchiyama |
IgE-activated mast cells in combination with pro-inflammatory factors induce T(h)2-promoting dendritic cells |
IgE-activated mast cells in combination with pro-inflammatory factors induce T(h)2-promoting dendritic cells |
IgE-activated mast cells in combination with pro-inflammatory factors induce T(h)2-promoting dendritic cells |
INTERNATIONAL IMMUNOLOGY, 18, 12, 1789-1799 |
INTERNATIONAL IMMUNOLOGY, 18, 12, 1789-1799 |
INTERNATIONAL IMMUNOLOGY, 18, 12, 1789-1799 |
2006/12 |
Refereed |
English |
Research paper(scientific journal) |
Disclose to all |
K Kawamura, N Kadowaki, R Suzuki, S Udagawa, S Kasaoka, N Utoguchi, T Kitawaki, N Sugimoto, N Okada, K Maruyama, T Uchiyama |
K Kawamura, N Kadowaki, R Suzuki, S Udagawa, S Kasaoka, N Utoguchi, T Kitawaki, N Sugimoto, N Okada, K Maruyama, T Uchiyama |
K Kawamura, N Kadowaki, R Suzuki, S Udagawa, S Kasaoka, N Utoguchi, T Kitawaki, N Sugimoto, N Okada, K Maruyama, T Uchiyama |
Dendritic cells that endocytosed antigen-containing IgG-liposomes elicit effective antitumor immunity |
Dendritic cells that endocytosed antigen-containing IgG-liposomes elicit effective antitumor immunity |
Dendritic cells that endocytosed antigen-containing IgG-liposomes elicit effective antitumor immunity |
JOURNAL OF IMMUNOTHERAPY, 29, 2, 165-174 |
JOURNAL OF IMMUNOTHERAPY, 29, 2, 165-174 |
JOURNAL OF IMMUNOTHERAPY, 29, 2, 165-174 |
2006/03 |
Refereed |
English |
Research paper(scientific journal) |
Disclose to all |
K Kawamura, N Kadowaki, T Kitawaki, T Uchiyama |
K Kawamura, N Kadowaki, T Kitawaki, T Uchiyama |
K Kawamura, N Kadowaki, T Kitawaki, T Uchiyama |
Virus-stimulated plasmacytoid dendritic cells induce CD4(+) cytotoxic regulatory T cells |
Virus-stimulated plasmacytoid dendritic cells induce CD4(+) cytotoxic regulatory T cells |
Virus-stimulated plasmacytoid dendritic cells induce CD4(+) cytotoxic regulatory T cells |
BLOOD, 107, 3, 1031-1038 |
BLOOD, 107, 3, 1031-1038 |
BLOOD, 107, 3, 1031-1038 |
2006/02 |
Refereed |
English |
Research paper(scientific journal) |
Disclose to all |
S Tabata, N Kadowaki, T Kitawaki, T Shimaoka, S Yonehara, O Yoshie, T Uchiyama |
S Tabata, N Kadowaki, T Kitawaki, T Shimaoka, S Yonehara, O Yoshie, T Uchiyama |
S Tabata, N Kadowaki, T Kitawaki, T Shimaoka, S Yonehara, O Yoshie, T Uchiyama |
Distribution and kinetics of SR-PSOX/CXCL16 and CXCR6 expression on human dendritic cell subsets and CD4(+) T cells |
Distribution and kinetics of SR-PSOX/CXCL16 and CXCR6 expression on human dendritic cell subsets and CD4(+) T cells |
Distribution and kinetics of SR-PSOX/CXCL16 and CXCR6 expression on human dendritic cell subsets and CD4(+) T cells |
JOURNAL OF LEUKOCYTE BIOLOGY, 77, 5, 777-786 |
JOURNAL OF LEUKOCYTE BIOLOGY, 77, 5, 777-786 |
JOURNAL OF LEUKOCYTE BIOLOGY, 77, 5, 777-786 |
2005/05 |
Refereed |
English |
Research paper(scientific journal) |
Disclose to all |
H Yagi, T Nomura, K Nakamura, S Yamazaki, T Kitawaki, S Hori, M Maeda, M Onodera, T Uchiyama, S Fujii, S Sakaguchi |
H Yagi, T Nomura, K Nakamura, S Yamazaki, T Kitawaki, S Hori, M Maeda, M Onodera, T Uchiyama, S Fujii, S Sakaguchi |
H Yagi, T Nomura, K Nakamura, S Yamazaki, T Kitawaki, S Hori, M Maeda, M Onodera, T Uchiyama, S Fujii, S Sakaguchi |
Crucial role of FOXP3 in the development and function of human CD25(+)CD4(+) regulatory T cells |
Crucial role of FOXP3 in the development and function of human CD25(+)CD4(+) regulatory T cells |
Crucial role of FOXP3 in the development and function of human CD25(+)CD4(+) regulatory T cells |
INTERNATIONAL IMMUNOLOGY, 16, 11, 1643-1656 |
INTERNATIONAL IMMUNOLOGY, 16, 11, 1643-1656 |
INTERNATIONAL IMMUNOLOGY, 16, 11, 1643-1656 |
2004/11 |
Refereed |
English |
Research paper(scientific journal) |
Disclose to all |
M Hishizawa, K Imada, T Kitawaki, M Ueda, N Kadowaki, T Uchiyama |
M Hishizawa, K Imada, T Kitawaki, M Ueda, N Kadowaki, T Uchiyama |
M Hishizawa, K Imada, T Kitawaki, M Ueda, N Kadowaki, T Uchiyama |
Depletion and impaired interferon-alpha-producing capacity of blood plasmacytoid dendritic cells in human T-cell leukaemia virus type I-infected individuals |
Depletion and impaired interferon-alpha-producing capacity of blood plasmacytoid dendritic cells in human T-cell leukaemia virus type I-infected individuals |
Depletion and impaired interferon-alpha-producing capacity of blood plasmacytoid dendritic cells in human T-cell leukaemia virus type I-infected individuals |
BRITISH JOURNAL OF HAEMATOLOGY, 125, 5, 568-575 |
BRITISH JOURNAL OF HAEMATOLOGY, 125, 5, 568-575 |
BRITISH JOURNAL OF HAEMATOLOGY, 125, 5, 568-575 |
2004/06 |
Refereed |
English |
Research paper(scientific journal) |
Disclose to all |
Haruhiko Yagi, Takashi Nomura, Kyoko Nakamura, Toshio Kitawaki, Masafumi Onodera, Takashi Uchiyama, Shingo Fujii, Shimon Sakaguchi |
Haruhiko Yagi, Takashi Nomura, Kyoko Nakamura, Toshio Kitawaki, Masafumi Onodera, Takashi Uchiyama, Shingo Fujii, Shimon Sakaguchi |
Haruhiko Yagi, Takashi Nomura, Kyoko Nakamura, Toshio Kitawaki, Masafumi Onodera, Takashi Uchiyama, Shingo Fujii, Shimon Sakaguchi |
Crucial role of FOXP3 in the development of human CD25+4+ regulatory T cells. |
Crucial role of FOXP3 in the development of human CD25+4+ regulatory T cells. |
Crucial role of FOXP3 in the development of human CD25+4+ regulatory T cells. |
Keystone Symposia Regulatory/Suppressor T Cells(2004.3.10-15. Banff Canada) |
Keystone Symposia Regulatory/Suppressor T Cells(2004.3.10-15. Banff Canada) |
Keystone Symposia Regulatory/Suppressor T Cells(2004.3.10-15. Banff Canada) |
2004 |
Refereed |
English |
|
Disclose to all |
C Ueda, M Nishikori, T Kitawaki, T Uchiyama, H Ohno |
C Ueda, M Nishikori, T Kitawaki, T Uchiyama, H Ohno |
C Ueda, M Nishikori, T Kitawaki, T Uchiyama, H Ohno |
Coexistent Rearrangements of c-MYC, BCL2, and BCL6 genes in a diffuse large B-cell lymphoma |
Coexistent Rearrangements of c-MYC, BCL2, and BCL6 genes in a diffuse large B-cell lymphoma |
Coexistent Rearrangements of c-MYC, BCL2, and BCL6 genes in a diffuse large B-cell lymphoma |
INTERNATIONAL JOURNAL OF HEMATOLOGY, 79, 1, 52-54 |
INTERNATIONAL JOURNAL OF HEMATOLOGY, 79, 1, 52-54 |
INTERNATIONAL JOURNAL OF HEMATOLOGY, 79, 1, 52-54 |
2004/01 |
Refereed |
English |
Research paper(scientific journal) |
Disclose to all |
T Kitawaki, N Kadowaki, T Ishikawa, T Ichinohe, T Uchiyama |
T Kitawaki, N Kadowaki, T Ishikawa, T Ichinohe, T Uchiyama |
T Kitawaki, N Kadowaki, T Ishikawa, T Ichinohe, T Uchiyama |
Compromised recovery of natural interferon-alpha/beta-producing cells after allogeneic hematopoietic stem cell transplantation complicated by acute graft-versus-host disease and glucocorticoid administration |
Compromised recovery of natural interferon-alpha/beta-producing cells after allogeneic hematopoietic stem cell transplantation complicated by acute graft-versus-host disease and glucocorticoid administration |
Compromised recovery of natural interferon-alpha/beta-producing cells after allogeneic hematopoietic stem cell transplantation complicated by acute graft-versus-host disease and glucocorticoid administration |
BONE MARROW TRANSPLANTATION, 32, 2, 187-194 |
BONE MARROW TRANSPLANTATION, 32, 2, 187-194 |
BONE MARROW TRANSPLANTATION, 32, 2, 187-194 |
2003/07 |
Refereed |
English |
Research paper(scientific journal) |
Disclose to all |
A Yonezawa, R Morita, A Takaori-Kondo, N Kadowaki, T Kitawaki, T Hori, T Uchiyama |
A Yonezawa, R Morita, A Takaori-Kondo, N Kadowaki, T Kitawaki, T Hori, T Uchiyama |
A Yonezawa, R Morita, A Takaori-Kondo, N Kadowaki, T Kitawaki, T Hori, T Uchiyama |
Natural alpha interferon-producing cells respond to human immunodeficiency virus type 1 with alpha interferon production and maturation into dendritic cells |
Natural alpha interferon-producing cells respond to human immunodeficiency virus type 1 with alpha interferon production and maturation into dendritic cells |
Natural alpha interferon-producing cells respond to human immunodeficiency virus type 1 with alpha interferon production and maturation into dendritic cells |
JOURNAL OF VIROLOGY, 77, 6, 3777-3784 |
JOURNAL OF VIROLOGY, 77, 6, 3777-3784 |
JOURNAL OF VIROLOGY, 77, 6, 3777-3784 |
2003/03 |
Refereed |
English |
Research paper(scientific journal) |
Disclose to all |
M. Jinnai, M. Hishizawa, T. Kitawaki, K. Imada, T. Ishikawa, H. Ohno, T. Uchiyama, T. Ohno |
M. Jinnai, M. Hishizawa, T. Kitawaki, K. Imada, T. Ishikawa, H. Ohno, T. Uchiyama, T. Ohno |
M. Jinnai, M. Hishizawa, T. Kitawaki, K. Imada, T. Ishikawa, H. Ohno, T. Uchiyama, T. Ohno |
Successful treatment of chronic myelogenous leukemia with extramedullary megakaryoblastic tumor by allogeneic bone marrow transplantation (from an unrelated donor) |
Successful treatment of chronic myelogenous leukemia with extramedullary megakaryoblastic tumor by allogeneic bone marrow transplantation (from an unrelated donor) |
Successful treatment of chronic myelogenous leukemia with extramedullary megakaryoblastic tumor by allogeneic bone marrow transplantation (from an unrelated donor) |
[Zasshi] Journal. Nihon Naika Gakkai, 91, 5, 1598-1600 |
[Zasshi] Journal. Nihon Naika Gakkai, 91, 5, 1598-1600 |
[Zasshi] Journal. Nihon Naika Gakkai, 91, 5, 1598-1600 |
2002 |
Refereed |
English |
|
Disclose to all |
T Kitawaki, N Yonetani, H Akasaka, T Akasaka, H Ohno, M Okuma |
T Kitawaki, N Yonetani, H Akasaka, T Akasaka, H Ohno, M Okuma |
T Kitawaki, N Yonetani, H Akasaka, T Akasaka, H Ohno, M Okuma |
Non-Hodgkin's lymphoma involving bilateral breasts |
Non-Hodgkin's lymphoma involving bilateral breasts |
Non-Hodgkin's lymphoma involving bilateral breasts |
INTERNAL MEDICINE, 37, 3, 311-315 |
INTERNAL MEDICINE, 37, 3, 311-315 |
INTERNAL MEDICINE, 37, 3, 311-315 |
1998/03 |
Refereed |
English |
Research paper(scientific journal) |
Disclose to all |
Y. Ueda, Y. Ikeda, S. Watanabe, T. Kitawaki, F. Matsuyama, H. Konishi, Y. Yagiri |
Y. Ueda, Y. Ikeda, S. Watanabe, T. Kitawaki, F. Matsuyama, H. Konishi, Y. Yagiri |
Y. Ueda, Y. Ikeda, S. Watanabe, T. Kitawaki, F. Matsuyama, H. Konishi, Y. Yagiri |
Changes in platelet demand in association with the spread of autologous peripheral blood progenitor cell transplantation |
Changes in platelet demand in association with the spread of autologous peripheral blood progenitor cell transplantation |
Changes in platelet demand in association with the spread of autologous peripheral blood progenitor cell transplantation |
Therapeutic Apheresis, 2, 4, 283-287 |
Therapeutic Apheresis, 2, 4, 283-287 |
Therapeutic Apheresis, 2, 4, 283-287 |
1998 |
Refereed |
English |
|
Disclose to all |
Hirai M, N Kadowaki, T Kitawaki, H Fujita, A Takaori-Kondo, R Fukui, K Miyake, T Maeda, S Kamihira, Y Miyachi, T Uchiyama |
Hirai M, N Kadowaki, T Kitawaki, H Fujita, A Takaori-Kondo, R Fukui, K Miyake, T Maeda, S Kamihira, Y Miyachi, T Uchiyama |
Hirai M, N Kadowaki, T Kitawaki, H Fujita, A Takaori-Kondo, R Fukui, K Miyake, T Maeda, S Kamihira, Y Miyachi, T Uchiyama |
A proteasome inhibitor bortezomib suppresses immunostimulatory activity of human plasmacytoid dendritic cells by targeting intracellular trafficking of nucleic acid-sensing Toll-like receptors and endoplasmic reticulum homeostasis. Blood in press. |
A proteasome inhibitor bortezomib suppresses immunostimulatory activity of human plasmacytoid dendritic cells by targeting intracellular trafficking of nucleic acid-sensing Toll-like receptors and endoplasmic reticulum homeostasis. Blood in press. |
A proteasome inhibitor bortezomib suppresses immunostimulatory activity of human plasmacytoid dendritic cells by targeting intracellular trafficking of nucleic acid-sensing Toll-like receptors and endoplasmic reticulum homeostasis. Blood in press. |
|
|
|
|
Refereed |
English |
|
Disclose to all |